Last reviewed · How we verify

To Explore a Bridging Index for the Effectiveness of the Clinical Trial

NCT04825340 NA UNKNOWN

To explore a bridging index for the effectiveness of the clinical trial with Nasal Spray Lyophilized Live Attenuated Influenza Vaccine

Details

Lead sponsorChangchun BCHT Biotechnology Co.
PhaseNA
StatusUNKNOWN
Enrolment450
Start dateFri Apr 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri Mar 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions